Wolverine Trading’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,300
Closed -$291K 6554
2020
Q4
$291K Buy
+4,300
New +$268K ﹤0.01% 3785
2018
Q3
Sell
-14,800
Closed -$525K 6140
2018
Q2
$525K Hold
14,800
﹤0.01% 3039
2018
Q1
$525K Buy
14,800
+3,900
+36% +$153K ﹤0.01% 3039
2017
Q4
$475K Buy
+10,900
New +$509K ﹤0.01% 3065
2017
Q2
Sell
-6,400
Closed -$290K 5164
2017
Q1
$290K Buy
6,400
+2,200
+52% +$109K ﹤0.01% 3065
2016
Q4
$221K Buy
+4,200
New +$203K ﹤0.01% 3635

Other funds holding SYNH

Wolverine Trading's SYNH Position: Q1 2018 in Review

Wolverine Trading sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2018, closing a stake of 7,243 shares — an estimated $284K sold.

Wolverine Trading first reported a position in SYNH in Q4 2016 and held it in 4 quarters. The position peaked at $402K in Q1 2017. 218 funds tracked by Wall St. Rank hold SYNH as of Q1 2018.

  • Wolverine Trading reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2018 after selling out during the quarter.
  • Wolverine Trading sold 7,243 Syneos Health, Inc. Class A Common Stock shares in Q1 2018, an estimated $284K.
  • Wolverine Trading first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 4 quarters.
  • Wolverine Trading's Syneos Health, Inc. Class A Common Stock position peaked at $402K in Q1 2017.
  • 218 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2018.

Based on Wolverine Trading's 13F filing for Q1 2018, filed 15 May 2018.